Cover Image
市場調查報告書

A型及B型流感:全球臨床實驗檢討

Influenza A and B Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 321704
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
A型及B型流感:全球臨床實驗檢討 Influenza A and B Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月22日 內容資訊: 英文 75 Pages
簡介

本報告提供A型及B型流感的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • A型及B型流感
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上A型及B型流感所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上A型及B型流感所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

A型及B型流感治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • 第一三共
    • GlaxoSmithKline plc
    • F. Hoffmann-La Roche Ltd.
    • Microgen Scientific Industrial Company for Immunobiological Medicines
    • Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd
    • Crucell N.V.
    • Biota Pharmaceuticals, Inc.
    • Biota Holdings Limited (Inactive)
    • Beech Tree Labs, Inc.
    • AstraZeneca PLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • British Columbia Centre for Disease Control
    • West China Hospital
    • NEOCI
    • TJ-27 Influenza study group
    • The National Institute of Allergy and Infectious Diseases
    • 福岡大學
    • University of Manitoba
    • University of Surrey

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2482CTIDB

GlobalData's clinical trial report, "Influenza A and B Infections Global Clinical Trials Review, H2, 2014" provides data on the Influenza A and B Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Influenza A and B Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Influenza A and B Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Influenza A and B Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Influenza A and B Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Influenza A and B Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Microgen Scientific Industrial Company for Immunobiological Medicines
      • Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines
      • Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd
      • Clinical Trial Overview of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd
      • Crucell N.V.
      • Clinical Trial Overview of Crucell N.V.
      • Biota Pharmaceuticals, Inc.
      • Clinical Trial Overview of Biota Pharmaceuticals, Inc.
      • Biota Holdings Limited (Inactive)
      • Clinical Trial Overview of Biota Holdings Limited (Inactive)
      • Beech Tree Labs, Inc.
      • Clinical Trial Overview of Beech Tree Labs, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
    • Clinical Trial Overview of Top Institutes / Government
      • British Columbia Centre for Disease Control
      • Clinical Trial Overview of British Columbia Centre for Disease Control
      • West China Hospital
      • Clinical Trial Overview of West China Hospital
      • Nagasaki Evaluation Organization for Clinical Interventions
      • Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions
      • TJ-27 Influenza study group
      • Clinical Trial Overview of TJ-27 Influenza study group
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Fukuoka University
      • Clinical Trial Overview of Fukuoka University
      • University of Manitoba
      • Clinical Trial Overview of University of Manitoba
      • University of Surrey
      • Clinical Trial Overview of University of Surrey
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Influenza A and B Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Influenza A and B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co Ltd, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Crucell N.V., 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Biota Pharmaceuticals, Inc., 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Biota Holdings Limited (Inactive), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Beech Tree Labs, Inc., 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by British Columbia Centre for Disease Control, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by TJ-27 Influenza study group, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fukuoka University, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Surrey, 2014*

List of Figures

  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Influenza A and B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Influenza A and B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Influenza A and B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Influenza A and B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Influenza A and B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Influenza A and B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top